Seres Therapeutics announces strategic collaboration with
Nestlé Health Science
for microbiome-based Clostridium difficile and inflammatory bowel disease therapies
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.